Atea Pharmaceuticals (AVIR) Net Equity Issued and Repurchased (2020 - 2026)
Atea Pharmaceuticals (AVIR) posted Net Equity Issued and Repurchased of $871,000 for Q1 2026, up 531.2% from $138,000 a year earlier.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
For FY2025, Atea Pharmaceuticals' Net Equity Issued and Repurchased came in at $201,000, down 24.7% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -77.1% (FY2020 to FY2025).
- In prior years, Atea Pharmaceuticals' Net Equity Issued and Repurchased was $267,000 in FY2024 (+3.9%), $257,000 in FY2023 (+11.7%), $230,000 in FY2022 (-84.3%) and $1.47 million in FY2021 (-99.5%).
- The Q1 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q4 2020.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with growth averaging 126.0%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2026, with growth of 531.2%; the weakest was Q4 2021, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Atea Pharmaceuticals | 417.87 Mn | 417.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 871,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 795,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 471,000.00 |
| Dec 31, 2020 | 210.97 Mn |
API Access
Atea Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();